Kester Capital has invested in Frontier Medical Products alongside a reinvestment from the Frontier management team, led by Nick Davis and Nigel Harris.
The transaction has been supported by new loan facilities from The Royal Bank of Scotland (RBS).
Founded in 1966, Frontier is manufacturer and supplier of pressure area care and infection control products to healthcare providers in the UK and continental Europe. Frontier’s portfolio of brands includes: Repose, a differentiated range of pressure area care devices; Sharpsafe, premium quality sharps disposal containers; and eXchange, specialist harm reduction products and services.
Frontier is based in Blackwood, Wales, and employs over 250 people.
Davis says: “We are pleased to have secured Kester Capital’s support for our continued growth plans. The investment is testament to the strength of the business and we look forward to capitalising on the growing market opportunity and the foundation we have built over the last 40 years. We are also pleased to be continuing our long standing relationship with RBS.”
Cameron Crockett, partner at Kester Capital, says: “Frontier is a good example of the type of business that Kester Capital looks to back. Pressure area care and infection control have emerged as areas of serious concern for healthcare providers across the world and Frontier has an enviable track record of helping its customers deal with these growing issues both in the UK and overseas.”
RBS provided term and ancillary facilities for the transaction.
Nick Evans, director at RBS, says: “We are very pleased to have been able to support this transaction and continue our relationship with Frontier, a strong local business that we have worked with since 1973.”
